These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1119 related articles for article (PubMed ID: 33991422)

  • 1. Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain.
    Mingot-Castellano ME; Alcalde-Mellado P; Pascual-Izquierdo C; Perez Rus G; Calo Pérez A; Martinez MP; López-Jaime FJ; Abalo Perez L; Gonzalez-Porras JR; López Fernández F; Caparrós Miranda IS; González-López TJ; Moreno Beltrán ME; Rubio Escuin R; Jimenez Bárcenas R;
    Br J Haematol; 2021 Aug; 194(3):537-541. PubMed ID: 33991422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia.
    Kaicker S; Martinko K; Bussel JB
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30051. PubMed ID: 36317671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2.
    Tsao HS; Chason HM; Fearon DM
    Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32439817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune thrombocytopenic purpura secondary to SARS-CoV-2 infection in a child with acute lymphoblastic leukaemia: a case report and review of literature.
    Dongre A; Jameel PZ; Deshmukh M; Bhandarkar S
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34740909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
    Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
    Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune thrombocytopenia preceded by asymptomatic COVID-19 infection].
    Ochiai T; Ando J; Harada S; Hiki M; Ando M; Komatsu N
    Rinsho Ketsueki; 2021; 62(1):58-60. PubMed ID: 33551428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune thrombocytopenia in the setting of acute SARS-CoV-2 infection.
    Caseiro Alves ME; Carmo F; Malato M; Cunha F
    BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37385718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical effect of SARS-CoV-2 infection in patients with immune thrombocytopenia.
    de la Cruz-Benito B; Rivas-Pollmar MI; Álvarez Román MT; Trelles-Martínez R; Martín-Salces M; Lázaro-Del Campo P; Ramírez-López A; García-Barcenilla S; Cebanu T; Acuña-Butta P; Monzón-Manzano E; González-Zorrilla E; Jiménez-Yuste V; Butta NV
    Br J Haematol; 2021 Mar; 192(6):973-977. PubMed ID: 33280085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia.
    Román MÁ; Jiménez Yuste V; García Barcenilla S; Ramírez López A; Monzón Manzano E; de la Cruz Benito B; Butta PA; Rivas Pollmar MI; Trelles Martínez R; González Zorrilla E; Martín Salces M; Cebanu T; Butta NV
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33804346
    [No Abstract]   [Full Text] [Related]  

  • 10. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
    J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.
    Baba Y; Sakai H; Kabasawa N; Harada H
    Intern Med; 2022 Jun; 61(12):1891-1895. PubMed ID: 35400701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
    Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
    Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pediatric refractory acute immune thrombocytopenic purpura secondary to asymptomatic SARS-CoV2].
    Dethier A; Gatineau-Sailliant S; Geurten C; Dresse MF
    Rev Med Liege; 2023 Jul; 78(7-8):393-398. PubMed ID: 37560947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia.
    Mori A; Onozawa M; Kobayashi M; Tsukamoto S; Senjo H; Ishio T; Yokoyama E; Izumiyama K; Saito M; Muraki H; Morioka M; Teshima T; Kondo T
    Br J Haematol; 2023 Mar; 200(6):717-721. PubMed ID: 36442510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world, single-center experience of SARS-CoV-2 vaccination in immune thrombocytopenia.
    Woolley P; Tailor A; Shah R; Westwood JP; Scully M
    J Thromb Haemost; 2022 Jun; 20(6):1476-1484. PubMed ID: 35313390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune thrombocytopenia and COVID-19: Case report and review of literature.
    Alonso-Beato R; Morales-Ortega A; Fernández FJH; Morón AIP; Ríos-Fernández R; Rubio JLC; Centeno NO
    Lupus; 2021 Aug; 30(9):1515-1521. PubMed ID: 34053365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience.
    Chou SC; Chang YC; Liao CK; Chen TC; Sun KJ; Huang WH; Wu YF
    Platelets; 2022 May; 33(4):531-535. PubMed ID: 35196955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group.
    González-López TJ; Bárez A; Bernardo-Gutiérrez A; Bernat S; Canaro-Hirnyk M; Entrena-Ureña L; Fernández-Fuertes F; Guinea de Castro JM; Jiménez-Bárcenas R; Pascual-Izquierdo C; Sánchez-González B; Jarque I
    Infect Dis Ther; 2023 Feb; 12(2):303-315. PubMed ID: 36520323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Sato K; Anayama M; Sumi M; Kobayashi H
    Rinsho Ketsueki; 2021; 62(12):1688-1693. PubMed ID: 35022338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary immune thrombocytopenia in children: Characteristics and outcome of a large cohort from two Spanish centres.
    Berrueco R; Sebastián E; Solsona M; González de Pablo J; Ruiz-Llobet A; Mesegué M; Gálvez E; Sevilla J
    Acta Paediatr; 2021 Jun; 110(6):1952-1958. PubMed ID: 33460494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.